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The SMN±SIP1 Complex Has an Essential Role
in Spliceosomal snRNP Biogenesis
Utz Fischer, Qing Liu, and Gideon Dreyfuss* splicing reaction (Moore et al., 1993; reviewed by Mad-
hani and Guthrie, 1994). Each spliceosomal snRNP con-Howard Hughes Medical Institute
sists of one (U1, U2, and U5) or two (U4/6) snRNAs, aDepartment of Biochemistry and Biophysics
common set of at least eight Sm proteins, termed B, B9,University of Pennsylvania School of Medicine
D1, D2, D3, E, F, and G, and specific polypeptides thatPhiladelphia, Pennsylvania 19104-6148
are associated with only one individual U snRNP (re-
viewed by LuÈ hrmann et al., 1990). With the exception
of U6, all spliceosomal snRNAs share two structuralSummary
features: the 59-terminal trimethylguanosine (m3G) cap
and a single-stranded, uridine-rich sequence flanked bySpinal muscular atrophy (SMA) is an often fatal neuro-
two hairpin loops, referred to as the Sm site (Branlantmuscular disease that has been directly linked to the
et al., 1982; Reddy and Busch, 1988). The Sm site is theprotein product of theSurvival ofMotor Neurons (SMN)
primary binding site for the Sm proteins. The remaininggene. The SMN protein is tightly associated with a
snRNA domains provide binding sites for the snRNA-novel protein, SIP1, and together they form a complex
specific snRNP proteins and for RNA±RNA interactionswith several spliceosomal snRNP proteins. Here we
(LuÈ hrmann et al., 1990). U6 differs from theother spliceo-show that the SMN±SIP1 complex is associated with
somal U snRNAs in that it contains a g-monomethyl capspliceosomal snRNAs U1 and U5 in the cytoplasm of
instead of the m3G cap and does not bind directly toXenopus oocytes. Antibodies directed against the
Sm proteins due to its lack of an Sm site (Reddy andSMN±SIP1 complex strongly interfere with the cyto-
Busch, 1988; Singh and Reddy, 1989).plasmic assembly of thecommon (Sm) snRNP proteins
The snRNP-specific proteins have snRNP-specificwith spliceosomal snRNAs and with the import of the
functions in the splicing reaction. In contrast, the onlysnRNP complex into the nucleus. Thus, the SMN±SIP1
known function for the Sm proteins is in the biogenesiscomplex is directly involved in the biogenesis of
of U snRNPs. The biogenesis of snRNPs U1, U2, U4,spliceosomal snRNPs. Defects in spliceosomalsnRNP
and U5 is a complex cycle that requires the bidirectionalbiogenesis may, therefore, be the cause of SMA.
transport of these snRNAs across the nuclear envelope
(DeRobertis, 1983; Mattaj and DeRobertis, 1985; Mattaj,Introduction
1986, 1988; Neuman de Vegvar and Dahlberg, 1990).
The snRNAs are transcribed in the nucleus by RNA poly-Spinal muscular atrophy (SMA) is a common autosomal
merase II and acquire a 59-terminal monomethyl (m7G)recessive disease characterized by degeneration of mo-
cap structure, while the Sm proteins are synthesized intor neurons in the spinal cord (Roberts et al., 1970;
the cytoplasm and do not migrate on their own into thePearn, 1973, 1978; Czeizei and Hamular, 1989). A human
nucleus. Instead, the snRNAs are exported from thegene that is directly linked to SMA, termed Survival of
nucleus to the cytoplasm, where the Sm proteins bind
Motor Neurons (SMN), has recently been identified (Le-
to the snRNAs' Sm site to form the Sm core. Thereafter,
febvre et al., 1995). Two copies of the SMN gene are
the m7G cap is hypermethylated to form the m3G caplocated in a 500 kb inverted repeat at chromosome5q13.
and the assembled U snRNP is imported into the nu-
In over 98% of all SMA patients, the telomeric copy of
cleus. The nuclear import of the m3G-capped spliceoso-SMN is deleted or mutated while the centromeric copy
mal snRNPs thus appears to require a nuclear import
is unaffected (Lefebvre et al., 1995). The SMN gene en-
signal that is generated only after both the m3G cap andcodes a 294±amino acid protein that does not have any the Sm core domain have been formed (Fischer and
obvious sequence similarity to other known proteins.
LuÈ hrmann, 1990; Hamm et al., 1990; Fischer et al., 1993).
SMN is found in both the cytoplasm and the nucleus in
The precise point in this cycle and the location in the
somatic cells. Strikingly, SMN is highly concentrated in
cell where the association of the snRNP-specific pro-
a novel nuclear structure, termed gems (gemini of coiled teins takes place are, in most cases, unknown. Much
bodies) (Liu and Dreyfuss, 1996; Liu et al., 1996). De- of the current knowledge of the spliceosomal snRNP
pending on the cell type, there are between two and biogenesis cycle has been derived from experiments in
eight gemsper nucleus, often in closeproximity tocoiled the Xenopus laevis oocyte. In the oocyte, large amounts
bodies. Indeed, coiled bodies and gems display similar of Sm proteins are stored in the cytoplasm, awaiting the
responses to transcriptional inhibitors and to low tem- burst of snRNA transcription that occurs during mid-
perature, suggesting a functional relationship between blastula transition, at which time copious amounts of
these nuclear bodies (Liu and Dreyfuss, 1996). No defini- spliceosomal snRNPs are assembled (Zeller et al., 1983).
tive functions have been identified for either gems or Thus, when U snRNAs are microinjected into the Xeno-
coiled bodies, and the function of the SMN protein is pus oocyte cytoplasm, they are assembled with Sm
unknown. proteins, receive a cap hypermethylation, and are sub-
The Sm class of small nuclear ribonucleoproteins sequently imported into the nucleus. The amphibian oo-
(snRNPs) U1, U2, U4/6, and U5 are major constituents cyte thus provides an excellent experimental system in
of the spliceosome, the catalytic center of thepre-mRNA which to dissect the snRNP biogenesis pathway (De-
Robertis, 1983; Mattaj and DeRobertis, 1985).
Formation of the Sm core domain in the cytoplasm*To whom correspondence should be addressed.
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requires specific interactions among the Sm proteins to
allow their binding to the Sm site. The Sm proteins D1,
D2, E, F, and G form a stable, RNA-free complex prior
to RNA binding (Fisher et al., 1985; Sauterer et al., 1988,
1990; Raker et al., 1996). The binding of the Sm protein
complex to the Sm site results in the formation of a
subcore that is then completed to the mature Sm core
by addition of a complex of B, B9, and D3 proteins (Raker
et al., 1996). It is not clear whether these ordered assem-
bly steps are assisted by additional, non-snRNP factors
or whether they proceed entirely by self assembly.
SMN is tightly associated in the cell with SIP1, and
together these two proteins are in a complex with Sm
and other snRNP-specific proteins (Liu et al., 1997).
However, the function, if any, of SMN and SIP1 in the
biogenesis, metabolism, or function of snRNPs could
not be determined from these observations. Here we
report that the SMN±SIP1 complex is associated with
spliceosomal snRNAs U1 and U5 in the cytoplasm of
Xenopus oocytes. Moreover, antibodies against SIP1
strongly inhibit Sm core assembly of spliceosomal
snRNPs U1, U2, U4, and U5 and their transport from the
cytoplasm to the nucleus. The anti-SMN antibodies we
have tested also affected snRNP assembly, but in
contrast to the anti-SIP1 antibodies, they stimulate
formation of the Sm core domain. Thus, the SMN±SIP1
complex is directly involved in the biogenesis of spliceo-
Figure 1. SMN and SIP1 Are Found in the Cytoplasm of Xenopussomal snRNPs. As SMN contains two distinct domains
Oocytes and Associate with Spliceosomal snRNAsthrough which it can directly bind to SIP1 and the Sm
(A) Protein from total Xenopus somatic cells (XL-177) or from oo-proteins, respectively (Liu et al., 1997), it can potentially
cytes dissected into nucleus and cytoplasm (O. Nuc and O. Cyto,serve to bring the SIP1±SMN±Sm complex together.
respectively) were fractionated by SDSPAGE and analyzedby West-
These findings describe a function for the SMA disease ern blotting with anti-SMN antibody (2B1) or anti-SIP1 antibody
gene product SMN and for SIP1 in a specific biochemical (2E17).
(B) Immunoprecipitation of spliceosomal U snRNAs with anti-SIP1pathway and suggest that defects in spliceosomal
and anti-SMN antibodies. Different mixtures of the indicated in vitrosnRNPs biogenesis is likely to be the molecular basis
synthesized 32P-labeled RNAs were injected into the cytoplasm offor the SMA phenotype.
oocytes. Three hours later, immunoprecipitations were carried out
with either anti-SMN antibody 2B1 or anti-SIP1 antibody 2E17. Im-
munoprecipitated RNA (IP) was analyzed by gel electrophoresis.
Results The supernatants (SUP) of the 2B1 immunoprecipitations are shown.
The supernatants from the 2E17 immunoprecipitations were similar
(data not shown).SMN and SIP1 Are Associated with Spliceosomal
snRNAs in the Cytoplasm
In the accompanying paper (Liu et al., 1997 [this issue in the cytoplasm (Figure 1A). The high cytoplasmic con-
of Cell]), we have described a novel protein complex centration of SMN and SIP1 in the Xenopus oocyte is
containing SMN, SIP1, and spliceosomal snRNP pro- reminiscent of the large amounts of Sm proteins that
teins, including several of the Sm proteins. The Xenopus are stored in the oocyte cytoplasm (Zeller et al., 1983).
oocyte provides a particularly advantageous system in In order to identify potential cellular targets for the
which to study spliceosomal snRNP biogenesis by use SMN±SIP1 complex, we tested if it can associate with
of microinjections (Mattaj and DeRobertis, 1985; Mattaj, RNA. Various 32P-labeled RNAs were generated by tran-
1986). We therefore wished to determine whether SMN scription in vitro, including mRNA, tRNA, U3 snoRNA,
and SIP1 are present in these oocytes. If so, the unique 5S RNA, and the spliceosomal snRNAs U1, U2, U4, U5,
features of this system can be used to investigate the and U6. Different mixtures of these RNAs were then
possible functions of these proteins in snRNP biogene- coinjected into the cytoplasm of oocytes and immuno-
sis. Immunoblotting with monoclonal antibodies to the precipitations were carried out with anti-SMN (2B1) and
human SMN and SIP1 proteins (2B1 and 2E17, respec- anti-SIP1 (2E17) antibodies. As shown in Figure 1B, only
tively) on Xenopus tissue culture cells detected proteins U1 and U5 snRNAs were efficiently precipitated, indicat-
of similar size to the corresponding human proteins. ing that they interact with SMN and SIP1. A weak but
cDNA cloning, sequencing, and transfection experi- reproducible immunoprecipitation of U4 snRNA was ob-
ments confirmed that these proteins are the Xenopus served. In contrast, other RNAs, including mRNA, tRNA,
homologs of SMN and SIP1 (Q. L. and G. D., unpublished U3 snoRNA, U6 snRNA, U2 snRNA (Figure 1B), and 5S
data). Surprisingly, however, unlike in somatic cells, rRNA (data not shown) were not immunoprecipitated at
where there is more SMN and SIP1 in the nucleus, in significant levels with the anti-SMN or anti-SIP1 anti-
bodies.the oocyte both proteins were found almost exclusively
SMN and SIP1 as snRNP Assembly Factors
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Figure 2. Anti-SMN and Anti-SIP1 Antibodies Can Immunoprecipi-
tate U1 and U5 snRNAs Only from the Cytoplasm
A mixture of 32P-labeled U1 and U5 snRNAs was injected into the
cytoplasm of oocytes. After incubation for 20 hr, the oocytes were
dissected into nuclear (N) and cytoplasmic (C) fractions, and RNAs
Figure 3. Anti-SIP1 Antibodies Interfere with the Biogenesis Cyclefrom both fractions were immunoprecipitated (IP) with either the
of Spliceosomal U snRNPsanti-Sm antibody Y12,anti-SMN antibody2B1, or anti-SIP1antibody
(A) Oocytes received a cytoplasmic injection of either water (-), anti-2E17. One-fifth of the total supernatant (SUP) was loaded on the
SMN antibody (2B1), anti-Sm antibody (Y12), or anti-SIP1 antibodygel.
(2E17). The same oocytes were nuclear injected 1 hr later with a
mixture of 32P-labeled U1, U5, and U6 snRNA. Fifteen hours later,
Since neither SMN norSIP1 is detectable in theoocyte the oocytes were dissected into nuclear (N) and cytoplasmic (C)
nucleus (Figure 1A), it seemed possible that they are fractions, and the injected RNAs were analyzed by electrophoresis
not associated with mature U1 and U5 snRNPs but on an RNA gel.
(B) Anti-SIP1 antibodies inhibit the nuclear import of all spliceosomalrather only during the cytoplasmic phase of their biogen-
snRNAs. In vitro transcribed, 32P-labeled snRNAs U1, U2, U4, andesis pathway. To test this directly, U1 and U5 snRNAs
U5 were injected into the cytoplasm of oocytes either alone (-) orwere injected into the cytoplasm of oocytes, and the
together with anti-SIP1 antibody (2E17). Oocytes were incubatedoocytes were incubated for 12 hr (Figure 2). After this
for an additional 15 hr and were then dissected into nuclear (N) and
incubation period, approximately 50% of the injected cytoplasmic (C) fractions. Injected RNAs were isolated and analyzed
snRNA was transported to the nucleus while the rest by electrophoresis on a denaturing RNA gel.
was still in the cytoplasm. Immunoprecipitations from
the nuclear and cytoplasmic fractions were then carried the biogenesis pathway of these snRNPs, i.e., in the
out with either anti-SMN antibody, anti-SIP1 antibody, assembly of snRNP proteins onto these snRNAs and/
or the anti-Sm monoclonal antibody Y12, and the coim- or in the nuclear import of these particles. We therefore
munoprecipitated RNAs were analyzed. Y12 recognizes examined whether anti-SMN or anti-SIP1 antibodies
a subset of the Sm proteins and was used in this experi-
have an effect on the nucleo-cytoplasmic transport of
ment to monitor the assembly of the Sm core domain
spliceosomal snRNPs (Figure 3). Anti-SMN (2B1), anti-
(Lerner et al., 1981). As previously reported (Mattaj, 1986;
SIP1 (2E17), or the anti-Sm (Y12) were injected into the
Fischer and LuÈ hrmann, 1990), U1 and U5 snRNAs were
cytoplasm of oocytes. One hour later, a mixture of U1,immunoprecipitated by Y12 in approximately equal
U5, and, as a control for nuclear injection, U6 snRNAamounts from the nucleus and cytoplasm (Figure 2).
was injected into the nuclei of the same oocytes, andThis indicated that the Sm proteins associate in the
the incubation was continued for 15 hr. The oocytescytoplasm with the snRNA and then move as an assem-
were then fractionated, and the RNAs in the nucleusbled and stable snRNP complex to the nucleus. In strik-
and cytoplasm were analyzed. In oocytes preinjecteding contrast, however, SMN and SIP1 association with
with water, nuclear-injected U1 and U5 snRNAs wereU1 and U5 snRNAs was observed only in the cytoplasm
exported to the cytoplasm and, after cytoplasmic as-(Figure 2).
sembly of the Sm core domain, reimported to the nu-Further evidence for the physiological relevance of
cleus (Figure 3A) (Hamm et al., 1990; Neuman de Vegvarthe interaction of SMN and SIP1 in the cytoplasm with
and Dahlberg, 1990; Terns et al., 1993). This was con-spliceosomal snRNPs was obtained following nuclear
firmed by immunoprecipitation of U1 and U5 snRNAsinjections of U1 snRNA. Only after export to the cytoplasm
with anti-Sm antibodies (data not shown) and by theand during the cytoplasmic phase of their biogenesis
observation that the nuclear pool of U1 snRNA had un-could U1 snRNA be immunoprecipitated with anti-SMN
dergone 39 end trimming (see Figure 3A, nuclear frac-or anti-SIP1 antibodies (data not shown). We conclude
tions). The latter has been previously shown to occur inthat the SMN±SIP1 complex interacts with U1 and U5
the cytoplasm prior to nuclear import (Neuman desnRNAs in the cytoplasm but not after these snRNAs
Vegvar and Dahlberg, 1990; Terns et al., 1993). In oo-have been assembled into snRNPs and imported into
cytes preinjected with Y12, U1 and U5 were also ex-the nucleus. Thus, SMN and SIP1 dissociate from the
ported to the cytoplasm; however, they were not reim-spliceosomal snRNPs either prior to nuclear entry or
ported to the nucleus, resulting in the accumulation ofshortly thereafter.
these RNAs in the cytoplasm (Figure 3A). This is because
upon binding to the Sm proteins, Y12 interferes with theAnti-SIP1 Antibodies Inhibit Spliceosomal
subsequent steps in the biogenesis of snRNPs that aresnRNP Assembly and Nuclear Import
required for their nuclear import (U. F. and G. D., unpub-The association of SMN and SIP1 with U1 and U5 snRNPs
in the cytoplasm suggested a role for these proteins in lished data; see also below). Surprisingly, a similar result
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was obtained in oocytes preinjected with anti-SIP1 anti-
bodies (Figure 3A). However, no effect on nuclear import
of U1 and U5 snRNA was observed in oocytes injected
with anti-SMN antibodies (Figure 3A).
We next asked whether anti-SIP1 antibodies inter-
fere with the nuclear import of the other spliceosomal
snRNPs. For this, in vitro transcribed snRNAs U1, U2,
U4, and U5 were injected into the cytoplasm of oocytes,
either without or with anti-SIP1 antibody, and nuclear
import was then analyzed 15 hr later (Figure 3B). Without
anti-SIP1 antibody injection, all snRNAs accumulated in
the nucleus to approximately 50%, although the import
of U4 was less efficient (Figure 3B). However, in the
presence of anti-SIP1 antibody, the nuclear import of
U1, U2, and U5 was almost completely inhibited, and
the import of U4 was slowed down by at least 50%
(Figure 3B). Thus, anti-SIP1 antibodies interfere with the
nuclear import of all spliceosomal U snRNPs regardless
of whether they can be efficiently immunoprecipitated
with the anti-SMN or anti-SIP1 antibodies. This suggests
that the interaction of SMN and SIP with some snRNAs
is transient and cannot be monitored by immunoprecipi-
tation (see Discussion).
As outlined above, assembly of the Sm core domain
Figure 4. Anti-SIP1 and Anti-SMN Antibodies Affect the Assemblyand the formation of the m3G cap are required for the
of the Sm Core Domain of Spliceosomal snRNPsnuclear import of U snRNPs (Mattaj and DeRobertis,
(A) Anti-SIP1 antibodies inhibit the assembly of the Sm core domain1985; Fischer and LuÈ hrmann, 1990; Hamm et al., 1990;
of all spliceosomal U snRNPs. Injections of either water (-), anti-SmFischer et al., 1993). Therefore, anti-SIP1 antibodies
antibody (Y12), anti-SIP1 antibody (2E17), anti-SMN antibody (2B1),
could inhibit U snRNP import by interfering either with or control antibody (SP2/0) were performed into the oocyte cyto-
the assembly of the Sm core or with the cap hypermeth- plasm. One hour later, the same oocytes were injected a second
ylation or both. Alternatively, and not mutually exclusive, time into the cytoplasm with a mixture of 32P-labeled U1, U5, and
U6 snRNAs. In the experiment shown in the lane labeled ªSIP1 postº,the antibody could directly interfere with the snRNP
U1, U5, and U6 snRNAs were injected 1 hr prior to the injection oftransport process, e.g., by blocking transport factors.
anti-SIP1 antibody. After incubation for an additional 1 hr, the oo-In order to determine the reason for the observed inhibi-
cytes were homogenized, and RNAs were immunoprecipitated with
tion of U snRNP nuclear import, the effect of anti-SIP1 anti-Sm antibody Y12 (IP Y12). Immunoprecipitated RNAs were ana-
antibodies on the assembly of the Sm core domain was lyzed by electrophoresis on an RNA gel with the corresponding
studied (Figure 4A). For this, anti-SIP1, anti-SMN or anti- supernatants (SUP Y12).
(B) The anti-SMN monoclonalantibody 2B1 stimulates the formationSm (Y12), and, as controls, nonimmune antibodies
of the Sm core domain. Stimulation of Sm protein binding ontoSP2/0 or water were injected into the cytoplasm of oo-
U5 snRNA in the presence of high concentrations of the anti-SMNcytes, followed by incubation for 1 hr before receiving
antibody 2B1. A mixture of 32P-labeled U5 and U6 snRNAs was
a second cytoplasmic injection of a mixture of 32P- injected into the cytoplasm of oocytes either with water (-) or with
labeled U1, U5, and U6 snRNAs. One hour later, the Sm anti-SMN and anti-SIP1 antibodies (2B1 and 2E17, respectively) at
core assembly on the injected RNAs was analyzed by either high (h, 3 mg/ml) or low (l, 1 mg/ml) concentrations. After a 1
hr incubation, the oocytes were homogenized, and the RNAs wereimmunoprecipitation with Y12 (Figure 4A). In control oo-
immunoprecipitated with the anti-Sm antibody Y12 (IP Y12). Immu-cytes preinjected with either water or SP2/0, both U1
noprecipitated RNAs were analyzed by electrophoresis on an RNAand U5 snRNAs were efficiently immunoprecipitated
gel alongside one-tenth of the supernatants (SUP Y12).
with Y12, indicating that these RNAs assembled with
the Sm proteins. As expected, U6 snRNA was not immu-
in Figure 4A, preinjection of anti-SIP1 antibodies stronglynoprecipitated because this RNA does not contain an
interfered with the Sm core assembly on both U2 andSm site and thus cannot bind Sm proteins. However,
U4 snRNAs, while in oocytes preinjected with water,the anti-SIP1 antibody completely inhibited the Sm core
both snRNAs assembled with the Sm proteins. The inhi-assembly on U1 and U5 snRNAs (Figure 4A). Y12 itself
bition of nuclear import of snRNAs U1, U2, U4, and U5strongly reduced the Sm core assembly on both U1 and
by anti-SIP1 antibodies is, therefore, at least partiallyU5 snRNAs in a similar fashion (Figure 4A). The anti-
due to the interference of the antibody with the Sm coreSMN antibody 2B1, in contrast, did not inhibit but rather
domain assembly. Thus, SIP1 is a cytoplasmic assemblyslightly stimulated assembly of Sm proteins (Figure 4A).
factor that mediates the formation of the Sm core do-If the snRNAs are injected 1 hr prior to injection of the
main on spliceosomal U snRNPs.anti-SIP1 antibody, no interference with subsequentY12
immunoprecipitation is observed. The observed inhibi-
Anti-SMN Monoclonal Antibody Stimulates Smtion of Sm core assembly by preinjection of anti-SIP1
Protein Binding onto the Sm Siteis therefore not due to a nonspecific occlusion of the
of U snRNAsSm epitope by the anti-SIP1 antibody (Figure 4A). Next,
Although SMN is in a tight complex with SIP1 and, there-we tested whether anti-SIP1 antibodies could also inter-
fere with the assembly of U2 and U4 snRNAs. As shown fore, is likely to form a functional unit with SIP1, the
SMN and SIP1 as snRNP Assembly Factors
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anti-SMN antibodies used in the experiments described snRNPs but rather are associated with them only during
the cytoplasmic phase of their biogenesis. Second, anti-above, unlike the anti-SIP1 antibodies, did not interfere
with U snRNP biogenesis. We therefore investigated SIP1 antibodies strongly interfere with the assembly of
the the Sm core domain of spliceosomal U snRNAs andfurther the function of SMN in snRNP assembly. As
shown in Figure 4B, injection of anti-SMN antibodies with their nuclear import. Third, anti-SMN antibodies
stimulate the assembly of Sm proteins onto the Sm site(2B1) does not inhibit snRNP assembly. However, we
noticed that upon injection of high concentrations (2 of spliceosomal U snRNAs. Finally, two distinct domains
in SMN have been identified that mediate its interactionto 3 mg/ml) of this anti-SMN antibody, the assembly of
snRNPs was often enhanced. To analyze this in more with several Sm proteins and with SIP1 (Liu et al., 1997),
in addition to its capacity to interact with itself (Liu anddetail, a mixture of U5 and U6 snRNAs was injected
along with either high (3 mg/ml) or low (1 mg/ml) concen- Dreyfuss, 1996). The different effects of anti-SMN and
anti-SIP1 antibodies on the assembly of splicesomal Utrations of the anti-SMN antibody 2B1 or the anti-SIP1
antibody 2E17 (Figure 4B). Sm protein binding onto snRNAs raise the possibility that SIP1 and SMN have
different, although related, functions in the Sm core as-these RNAs was then assessed by immunoprecipitation
with the anti-Sm antibody Y12 1 hr later. After 1 hr, sembly process. This conclusion is consistent with the
observation that SMN but not SIP1 directly interactsthe assembly of Sm proteins onto U snRNAs is not yet
complete, thus allowing a more quantitative evaluation with a subset of Sm proteins (Liu et al., 1997). Moreover,
SMN can likely simultaneously interact via two distinctof the efficiency of Sm protein binding. In the absence
of coinjected antibody, U5 but not U6 was precipitated, binding domains with SIP1 and Sm proteins. Therefore,
it is possible that SMN can serve to recruit the Sm pro-indicating Sm core formation on U5 snRNA. However,
while low concentrations of 2B1 had only a slight stimu- teins to the Sm site of spliceosomal snRNAs, while SIP1
may have a more direct function in mediating the assem-latory effect on Sm protein binding, coinjection of higher
2B1 concentrations significantly enhanced the assem- bly of the Sm proteins onto the Sm site. Alternatively,
upon binding to Sm proteins, SMN may prevent theirbly (2- to 3-fold) (Figure 4B). Coinjected anti-SIP1 anti-
body, in contrast, inhibited the assembly of Sm proteins misassembly onto RNAs other than U snRNAs. It is,
however, clear both from the tight association of SMNonto U5 snRNA almost entirely at both low and high
antibody concentrations (Figure 4B). Thus, 2B1 stimu- and SIP1 as well as from the effect that antibodies to
both proteins have on Sm core domain assembly thatlates Sm protein binding onto U5 snRNA and hence Sm
core formation, indicating that SMN is also involved in both proteins play a role in snRNP assembly. We note,
however, that the lack of inhibitory effect of the mono-spliceosomal U snRNP assembly. We further found that
2B1 stimulates Sm protein binding onto an artificial clonal anti-SMN antibodies that we used on snRNP as-
sembly may simply be because of the location of thesnRNA, termed SmII RNA, that consists of the Sm site
and stem/loop E of U1 snRNA and an artificial stem/ particular epitope, and other anti-SMN may inhibit this
process. It is not clear why only U1 and U5 but not U2loop 59 to the Sm site. The capacity of this RNA to bind
Sm protein is severely compromised, and, as a conse- and U4 snRNA can be efficiently immunoprecipitated
with anti-SIP1 and anti-SMN antibodies, although thequence of this, its nuclear import is reduced (Fischer et
al., 1993). Using the same injection strategy as de- assembly of the Sm core domain of all spliceosomal U
snRNPs is strongly inhibited by anti-SIP1 antibodies.scribed above, a strong stimulation of Sm protein bind-
ing onto SmII RNA was observed, and, as a conse- One possible explanation is that the interaction of SMN
and SIP1 with U2 and U4 snRNA is more transient and,quence, SmII was efficiently imported into the nucleus
(data not shown). Taken together, these data and those therefore, can not be readily detected by immunoprecip-
itation. In supportof the role of SIP1 inU snRNP biogene-presented in the preceeding sections strongly suggest
that both SIP1 and SMN are directly involved in the sis, SIP1 has significant sequence homology (Liu et al.,
1997) to theSaccharomyces cerevisiaeprotein Brr1 (No-assembly of the Sm core domain of spliceosomal U
snRNPs. ble and Guthrie, 1996a, 1996b), mutations inwhich result
in defects in U snRNP biogenesis. Moreover, genetic
criteria suggest that Brr1 interacts with the yeast homo-
Discussion log of the Sm D1 protein.
A great deal of information on the detailed assembly
In this study, microinjection experiments in Xenopus pathway of the Sm core domain has been recently ob-
oocytes provided important insight into the function of tained. Importantly, it hasbeen shown that specific inter-
the SMA disease gene product SMN and its associated actions among Sm proteins precede their binding to the
protein SIP1. SMN and SIP1 are tightly associated as RNA (Fisher et al., 1985; Sauterer et al., 1988, 1990;
two subunitsof a heteromeric protein complex,and both Raker et al., 1996). According to this scheme, the D1,
are found in the ooctye cytoplasm. We have detected D2, E, F, and G proteins first form an RNA-free complex
a complex that contains SMN, SIP1, the Sm proteins, that is only then capable of binding to the Sm site on
and several additional splicesomal snRNP-specific pro- the RNA. Thereafter, binding of a protein complex that
teins (Liu et al., 1997). Here we show that the SMN±SIP1 includes B, B9, and D3 proteins completes the assembly
complex has an essential role in spliceosomal snRNP of the Sm core domain. The Y12 antibody that we used
biogenesis. Several lines of evidence lead to this conclu- in this study to monitor the assembly of the Sm core
sion. First, SMN and SIP1 are specifically associated in domain is not specific to one particular Sm protein but
the cytoplasm with U1 and U5 snRNAs but not with rather recognizes all of the individual Sm protein assem-
nuclear snRNPs and not with other RNAs tested so far. bly intermediates (Raker et al., 1996). Thus, the fact
that Y12 does not immunoprecipitate U snRNAs afterThus, they are not components of mature nuclear
Cell
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Western blot analysis, proteins were separated on an SDS-poly-injection of anti-SIP1 antibody suggests that none of
acrylamide gel (12.5%) and subsequently transferred to a nitrocellu-the Sm proteins was able to bind the Sm site under
lose membrane (Schleicher and Schuell, Inc., Keene, NH) using athese conditions. It is, therefore, likely that the SMN±
BioTrans Model B Transblot apparatus (Gelman Science) according
SIP1 complex is involved at an early stage in the Sm core to the manufacturer's instructions. After protein transfer, the blotting
assembly; i.e., in a step that proceeds the Sm protein membrane was incubated in phosphate-buffered saline (PBS) con-
taining 5% nonfat milk for 1 hr at room temperature, rinsed withbinding to the Sm site of the snRNAs.
PBS, and then incubated in the same solution with the primaryWe have previously shown that the SMN protein also
antibody for 1 hr at room temperature. The membrane was theninteracts with fibrillarin and with the hnRNP U protein
washed three times with PBS containing 0.1% Tween 20, and bound(Liu and Dreyfuss, 1996). Fibrillarin is a common compo-
antibodies were detected using peroxidase-conjugated goat anti-
nent of small nucleolar RNPs (snoRNPs) and is perhaps mouse IgG plus IgM (Jackson ImmunoResearch Laboratories). Pro-
the snoRNPs' functional equivalent of the common Sm teins were visualized using an ECL Western blotting detection kit
(Amersham) after washing the membrane three times in PBS con-proteins of splicesomal snRNPs (Tyc and Steitz, 1989;
taining 0.1% Tween 20.Maxwell and Fournier, 1995). It is, therefore, possible
that SMN and SIP1 also play a role in snoRNP assembly
Oocyte Injectionsin a fashion similar to the one that we have found it to
Injections were carried out as described in Fischer et al. (1993). In
play in splicesomal snRNP assembly. In this case, it can brief, oocytes were incubated for 3 hr in modified Barth's solution
be anticipated that this function will be fulfilled by the containing 0.2% collagenase type II (Sigma). Defolliculated stage V
nuclear pool of SMN and SIP1 found in somatic cells, and VI oocytes were collected and usually used on the same day
for microinjection.because snoRNAs remain in the nucleus and snoRNP
In a typical injection experiment, 30 nl of 32P-labeled RNA (1 3biogenesis does not have a cytoplasmic phase (Terns
106 cpm/ml; total concentration of 0.7 mM) was injected either intoand Dahlberg, 1994; Terns et al., 1995). It can, therefore,
the nucleus or into the cytoplasm. For the antibody inhibition experi-
be envisioned that snoRNP assembly also involves SMN ments, oocytes were preinjected with antibody (1 mg/ml or 3 mg/ml
in the nucleoplasm or in gems. The close association in Figure 4B) and incubated for 1 hr before they received a second
and relationship between gems and coiled bodies, injection of [32P]RNA. Nucleo-cytoplasmic transport of injected
RNAs was monitored by dissection of the oocytes into nuclear andwhich are enriched in fibrillarin, lend further support for
cytoplasmic fractions. Both fractions were incubated for 20 min inthis thought. SMN and SIP1 may also play a role in the
homogenization buffer, and the RNAs were isolated and analyzedbiogenesis of other nuclear RNPs, and further experi-
by electrophoresis on denaturing RNA gels as described in Hamm
ments will be necessary to examine this possibility. et al. (1990).
Our findings connect the SMA disease gene SMN to a
specific biochemical pathway and identify two proteins, Immunoprecipitation of RNA±Protein Complexes
For immunoprecipitation of RNA±protein complexes (Fischer et al.,SMN and SIP1, that are essential to the fundamental
1993), the injected oocytes were homogenized in 300 ml of ice-coldcellular process of splicesomal snRNP biogenesis. As
PBS (pH 7.4). The insoluble fraction was pelleted by centrifugation,motor neurons are the target tissue in SMA, it is of great
and the clear supernatant was transferred into a new 1.5 ml Eppen-interest that these cells also contain very high levels of
dorf tube containing antibodies bound to protein G-Sepharose
SMN and SIP1 and have very prominently staining gems (Pharmacia). This mixture was incubated with constant shaking for
(Lefebvre et al., 1997). Significantly, severely affected 1 hr at 48C and subsequently washed five times with 1 ml aliquots
of ice-cold PBS. Bound RNAs were isolated by phenol extraction(type I) SMA patients have reduced levels of the SMN
for 1 hr, precipitated with ethanol, and analyzed by denaturing gelprotein and show no detectable immunohistochemical
electrophoresis.staining with antibodies to SMN or SIP1 in their motor
neurons (Lefebvre et al., 1997). It is, therefore, possible
Plasmid DNA In Vitro Transcription and Translation
that SMA results from a defect in snRNP assembly in Plasmids coding for U1, U2, U4, U5, and U6 snRNAs have been
motor neurons. It will be of interest todetermine if indeed described in Hamm et al. (1990) and Fischer et al. (1993, 1995).
there is a decrease in splicesomal snRNP assembly in Plasmids encoding dihydrofolate reductase mRNA (DHFR) and
tRNAmet were described in Jarmolowski and Mattaj (1993) and Jar-motor neurons of SMA type I patients. It is, however,
molowski et al. (1994) and in Fischer et al. (1995). A plasmid codingalso possible that several additional defects occur in
for the human U3 snoRNA was a kind gift of C. Marshallsay. Clonesmotor neurons of SMA patients. For example, the stimu-
encoding the Sm proteins B, D1, D2, D3, E, F, and G are described
lation of inappropriate assembly of Smproteins on RNAs in Raker et al. (1996). The clone encoding SIP1 is described in Liu
seen upon microinjection of anti-SMN antibodies raises et al. (1997). In vitro transcription of 32P-labeled RNAs was carried
the possibility that there may be missassembly of Sm out exactly as described in Fischer et al. (1993). Labeled RNA was
precipitated in ethanol and resuspended in water. For nuclear injec-proteins on variousRNAs in patient cells. The biogenesis
tion, RNA was dissolved in water containing 10 mg/ml dextran blueof other RNPs, in addition to splicesomal snRNPs, may
(MW 1,000,000). In vitro translation of 35S-labeled proteins was car-also be affected in these patients. Experiments are in
ried out using a combined transcription and translation kit (TnT)
progress to address these questions. (Promega) according to the instructions of the manufacturer.
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